A study presented today at the IASLC World Conference on Lung Cancer 2022 in Vienna disclosed the clinical-relevant intertumoral heterogeneity of non-small cell lung cancer (NSCLC) driven by MET exon 14 skipping.
from The Medical News https://ift.tt/WA5T2xh
from The Medical News https://ift.tt/WA5T2xh